These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8244166)

  • 21. Ovarian cancer. The most lethal gynecologic malignancy.
    Brucks JA
    Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing serum CA 125 levels in normal women.
    Grover S; Quinn MA; Weideman P; Koh H
    Obstet Gynecol; 1992 Apr; 79(4):511-4. PubMed ID: 1553167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound examination for detection of ovarian carcinoma in risk groups.
    Andolf E; Jørgensen C; Astedt B
    Obstet Gynecol; 1990 Jan; 75(1):106-9. PubMed ID: 2404221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for early ovarian cancer.
    Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
    Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer. Early diagnosis and screening.
    Einhorn N
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):843-50. PubMed ID: 1500389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is a normal CA125 level?
    Alagoz T; Buller RE; Berman M; Anderson B; Manetta A; DiSaia P
    Gynecol Oncol; 1994 Apr; 53(1):93-7. PubMed ID: 8175027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.
    Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T; Oi H
    Gynecol Obstet Invest; 2008; 65(2):133-8. PubMed ID: 17957102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CA 125 levels in menopausal women.
    Westhoff C; Gollub E; Patel J; Rivera H; Bast R
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):428-31. PubMed ID: 2381621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.
    Bosse K; Rhiem K; Wappenschmidt B; Hellmich M; Madeja M; Ortmann M; Mallmann P; Schmutzler R
    Gynecol Oncol; 2006 Dec; 103(3):1077-82. PubMed ID: 16904167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging.
    Weiner Z; Beck D; Shteiner M; Borovik R; Ben-Shachar M; Robinzon E; Brandes JM
    J Ultrasound Med; 1993 Jul; 12(7):387-93. PubMed ID: 8355333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome.
    Chen KT; Schooley JL; Flam MS
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):93S-94S. PubMed ID: 4022524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for ovarian cancer: not worthwhile for most patients.
    Wong JG; Feussner JR
    N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
    Holbert TR
    Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened.
    van Nagell JR; Higgins RV; Donaldson ES; Gallion HH; Powell DE; Pavlik EJ; Woods CH; Thompson EA
    Cancer; 1990 Feb; 65(3):573-7. PubMed ID: 2404560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.